Priorities and Recommendations to Make ALS a Livable Disease Emanating from the 2024 National Academies of Sciences, Engineering, and Medicine Report Living with ALS
Annals of Neurology · 2024-12 · 96 (6) · 1035-1039
DOI: 10.1002/ana.27097 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of Neurology, online erschienen am 10.10.2024. Verfasst von Ileana M Howard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation Care Services, VA Puget Sound Healthcare System, Seattle, WA, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ATSDR CDC HHS, NINDS NIH HHS, Charles H. Abdalian, Jr. ALS Research Fund.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a relentless, fatal neurodegenerative disease. The progressive loss of voluntary muscle function, diagnostic delays, lack of effective treatments, and challenges accessing multidisciplinary care and resources have tremendous impact on quality of life. The congressionally directed ALS committee of the National Academies of Science, Engineering, and Medicine, in their 2024 report “Living with ALS,” recommends critical actions for specific United States stakeholders to make ALS a livable disease over the next decade. This review summarizes the context and recommendations of the report. Advocacy efforts are critical to make these recommendations a reality for the ALS community. ANN NEUROL 2024;96:1035–1039
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Rehabilitation Care Services, VA Puget Sound Healthcare System, Seattle, WA, USA.
- Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA.
- Department of Neurology, Sean M. Healy and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- School of Public Health, Yale University, New Haven, CT, USA.
- Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
- Department of Neurology, College of Medicine, Medical University of South Carolina, Charleston, SC, USA.
ORCID-Profile: Merit E Cudkowicz, Eva L Feldman
Förderung
- ATSDR CDC HHS
- NINDS NIH HHS
- Charles H. Abdalian, Jr. ALS Research Fund
- NeuroNetwork for Emerging Therapies
- NIEHS NIH HHS
- ACL HHS
- American Academy of Neurology
- ALS One
Zitieren
APA
Howard, I. M., Babu, S., Carter, C., Sakowski, S. A., Kurent, J. E., Cudkowicz, M. E., & Feldman, E. L. (2024). Priorities and Recommendations to Make ALS a Livable Disease Emanating from the 2024 National Academies of Sciences, Engineering, and Medicine Report Living with ALS. Annals of Neurology, 96(6), 1035-1039. https://doi.org/10.1002/ana.27097
Vancouver
Howard IM, Babu S, Carter C, Sakowski SA, Kurent JE, Cudkowicz ME, et al. Priorities and Recommendations to Make ALS a Livable Disease Emanating from the 2024 National Academies of Sciences, Engineering, and Medicine Report Living with ALS. Annals of Neurology. 2024;96(6):1035-1039. doi:10.1002/ana.27097
BibTeX
@article{Howard2024,
author = {Howard, Ileana M and Babu, Suma and Carter, Chelsey and Sakowski, Stacey A and Kurent, Jerome E and Cudkowicz, Merit E and Feldman, Eva L},
title = {Priorities and Recommendations to Make ALS a Livable Disease Emanating from the 2024 National Academies of Sciences, Engineering, and Medicine Report Living with ALS},
journal = {Annals of Neurology},
year = {2024},
volume = {96},
number = {6},
pages = {1035--1039},
doi = {10.1002/ana.27097}
}
EUVIMED